Vanishing disc neovascularization following intravitreal bevacizumab (Avastin) injection

Archives of Ophthalmology

Volumn 124, Issue 9, 2006, Pages 1365-

  Friedlander, Steven M ^a   Welch, Robert M ^b  

^a Nevada Retina Associates   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CASE REPORT; DIABETIC RETINOPATHY; DRUG TOLERANCE; HUMAN; INFORMED CONSENT; LASER COAGULATION; MALE; PRIORITY JOURNAL; RETINA MACULA EDEMA; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADULT; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; MALE; OPTIC DISK; RETINAL NEOVASCULARIZATION;

EID: 33748612163     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.9.1365     Document Type: Article

References (2)

1. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336-339.
2. Reichel E. Intravitreal bevacizumab for choroidal neovascularization and cystoid macular edema: a cost-effective treatment? Ophthalmic Surg Lasers Imaging. 2005;36:270-271.